FDA staff affirms efficacy of Vertex's hepatitis C drug telaprevir

04/26/2011 | Boston Globe (tiered subscription model), The · Bloomberg

FDA reviewers backed pivotal trial data indicating that adding Vertex Pharmaceuticals' telaprevir to standard combination therapy is effective in curing hepatitis C and cutting down duration of treatment. An advisory panel will decide Thursday whether to recommend the drug's approval.

View Full Article in:

Boston Globe (tiered subscription model), The · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX